Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Clinical trial NCT04341129 · COMPLETED

Trial details

NCT number: NCT04341129
Sponsor: University of Chicago
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms Breast Diseases Breast Fibroadenoma Breast Cancer

Start date: 2020-07-13
Primary completion: 2023-06-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.